NMPA-2021-0084-V384

Type II variation for application NMPA-2021-0084. Type II variation: Formulation Change for Semaglutidex — critical change

Variation Number
NMPA-2021-0084-V384
Type
Type II
Application
NMPA-2021-0084
Change
CHG-2021-0084
Status
Draft
Fee
€10,095
Submitted
2022-12-07
Approved
—
Description

Type II variation: Formulation Change for Semaglutidex — critical change